Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: The role of IFN alpha in autoimmune disease

Review

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus

Yihong Yao*, Brandon W Higgs, Laura Richman, Barbara White and Bahija Jallal

Arthritis Research & Therapy 2010, 12(Suppl 1):S6  doi:10.1186/ar2887

Article Metrics

5255
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 48 accesses
  • Last 365 days: 564 accesses
  • All time: 5255 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information